Effect of VX-770 in Persons with Cystic Fibrosis and the G551D- <i>CFTR</i> MutationFrank J. Accurso, Bonnie W. Ramsey, Moira L. Aitken et al.|New England Journal of Medicine|2010Cited by 802
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the <i>F508del-CFTR</i> mutationJohn P. Clancy, Michael W. Konstan, Steven M. Rowe et al.|Thorax|2011Cited by 496
Egr-1 Regulates Autophagy in Cigarette Smoke-Induced Chronic Obstructive Pulmonary DiseaseZhi-Hua Chen, Augustine M.K. Choi, Hong Pyo Kim et al.|PLoS ONE|2008Cited by 464
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary diseaseWen Ning, Augustine M.K. Choi, Chaojun Li et al.|Proceedings of the National Academy of Sciences|2004Cited by 327
Cellular and Humoral Autoreactivity in Idiopathic Pulmonary FibrosisCarol Feghali‐Bostwick, Steven R. Duncan, Christopher G. Tsai et al.|The Journal of Immunology|2007Cited by 160